Eroding research base

Print edition : August 19, 2016

Researchers at work in a laboratory of Eisai Pharmaceuticals in Visakhapatnam, a file picture. In recent years, the pharma industry, faced with litigation on its generic formulations from MNCs for patent infringement, seems to be slowly giving the ground it had held for decades. Photo: K.R. DEEPAK

An analysis of data shows that economic liberalisation has not, as its proponents said it would, boosted domestic investment or expenditure in R&D or spurred innovation in indigenous product development.
    This article is closed for comments.
    Please Email the Editor